The HelioLiver Test is a novel, blood-based technique to detect specific markers in DNA that indicate higher likelihood of hepatocellular carcinoma (HCC). HelioLiver requires only a simple blood draw that can be conducted during the same provider visit, instead of needing to schedule an additional appointment.
HelioLiver can help detect HCC earlier, allowing patients access to more curative treatment options and improve outcomes overall.
Follow provider guidelines to follow up with additional
diagnostic imaging
Continued surveillance every 3-6 months, depending on
provider guidance
Providers can directly
order tests online or by
paper TRF
Use the materials in our
test kit for a single blood
draw
A return shipping label
included in our test kit
Our average turnaround
time is 7-10 days for complete
analysis
Uploaded directly to our
provider portal for easy
access
Routine surveillance is critical for patients to catch cancer early before it spreads. We partner with physicians to help ensure patients maintain the recommended schedule for liver cancer testing.
Testing intervals for HCC surveillance are based on a balance between the tumor doubling time and the cost of the surveillance test. Guidelines recommend patients at high risk for HCC, such as cirrhosis, hereditary hemochromatosis, or chronic hepatitis B infection (even without cirrhosis), undergo surveillance every 6 months